Gut Microbiota as a Mechanistic Nexus between Type 2 Diabetes and Alzheimer’s Disease: Insulin Resistance, Neuroinflammation, and Functional Food Strategies
4 affiliations
- 1Department of Food and Nutrition, College of Health and Life Science, Korea National University of Transportation, Chungbuk 27909, Korea
- 2Department of R&D, Daily Manufacturing, Rockwell, NC 28138, USA
- 3Department of Food and Nutrition, Obesity/Diabetes Research Center, Hoseo University, Chungnam 31499, Korea
- 4Department of Bioconvergence, Hoseo University, Chungnam 31499, Korea
Abstract
Type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD) share substantial pathological overlap, including brain-specific insulin resistance driven by impaired insulin receptor substrate-1/phosphoinositide 3-kinase/protein kinase B signaling, glycogen synthase kinase-3β dysregulation, tau hyperphosphorylation, and amyloid-β accumulation. Brain-insulin resistance is a key mechanistic link between peripheral metabolic dysfunction and neurodegeneration, although the upstream regulatory pathways remain incompletely defined. Gastrointestinal depletion of butyrate-producing microbial taxa and enrichment of pro-inflammatory genera have been independently documented in T2DM and AD. Gut microbiota dysbiosis propagates insulin resistance through at least five pathways: short-chain fatty acid depletion, lipopolysaccharide (LPS)-mediated endotoxemia, bile acid dysregulation, tryptophan-kynurenine imbalance, and vagus nerve disruption. Critically, LPS translocation and kynurenine-driven neurotoxicity propagate AD-relevant neuroinflammation independently of peripheral metabolic dysfunction, implicating a bidirectional gut-brain mechanism. These risks are amplified in Asian populations, who exhibit a lower pancreatic β-cell mass and attenuated insulin secretion that confer disproportionate vulnerability to glucotoxic cycling and its neurological complications. Such a population-specific dimension remains largely absent from reviews. Against this backdrop, traditional Asian fermented foods (chungkookjang, kimchi, and natto) and plant-derived functional ingredients (Eucommia ulmoides, gooseberry, and black garlic) have a preclinical capacity to restore microbial balance, attenuate insulin resistance, and exert neuroprotection. This review integrates these strands into a unified mechanistic and translational framework, positioning gut microbiota modulation through culturally grounded dietary strategies as a tractable approach to reducing the converging burdens of T2DM and AD in Asians.
Related
- Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention
- Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation
- TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction
- Akkermansia muciniphila Ameliorates Midlife Obesity-Induced Cognitive Impairment via the Microbiota-Metabolism-Neuroinflammation Axis
- Gut microbiota dysbiosis in pediatric acute lymphoblastic leukemia: clinical consequences, mechanistic insights, and microbiota-targeted interventions.
BibTeX
@article{bae2026microbiota,
title = {{Gut Microbiota as a Mechanistic Nexus between Type 2 Diabetes and Alzheimer’s Disease: Insulin Resistance, Neuroinflammation, and Functional Food Strategies}},
author = {Yun-Jung Bae and James W. Daily and Sunmin Park},
journal = {Preventive Nutrition and Food Science},
year = {2026},
month = oct,
doi = {10.3746/pnf.2026.151},
url = {https://doi.org/10.3746/pnf.2026.151},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Gut Microbiota as a Mechanistic Nexus between Type 2 Diabetes and Alzheimer’s Disease: Insulin Resistance, Neuroinflammation, and Functional Food Strategies
AU - Yun-Jung Bae
AU - James W. Daily
AU - Sunmin Park
PY - 2026
DA - 2026/10/13
JO - Preventive Nutrition and Food Science
DO - 10.3746/pnf.2026.151
UR - https://doi.org/10.3746/pnf.2026.151
AB - Type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD) share substantial pathological overlap, including brain-specific insulin resistance driven by impaired insulin receptor substrate-1/phosphoinositide 3-kinase/protein kinase B signaling, glycogen synthase kinase-3β dysregulation, tau hyperphosphorylation, and amyloid-β accumulation. Brain-insulin resistance is a key mechanistic link between peripheral metabolic dysfunction and neurodegeneration, although the upstream regulatory pathways remain incompletely defined. Gastrointestinal depletion of butyrate-producing microbial taxa and enrichment of pro-inflammatory genera have been independently documented in T2DM and AD. Gut microbiota dysbiosis propagates insulin resistance through at least five pathways: short-chain fatty acid depletion, lipopolysaccharide (LPS)-mediated endotoxemia, bile acid dysregulation, tryptophan-kynurenine imbalance, and vagus nerve disruption. Critically, LPS translocation and kynurenine-driven neurotoxicity propagate AD-relevant neuroinflammation independently of peripheral metabolic dysfunction, implicating a bidirectional gut-brain mechanism. These risks are amplified in Asian populations, who exhibit a lower pancreatic β-cell mass and attenuated insulin secretion that confer disproportionate vulnerability to glucotoxic cycling and its neurological complications. Such a population-specific dimension remains largely absent from reviews. Against this backdrop, traditional Asian fermented foods (chungkookjang, kimchi, and natto) and plant-derived functional ingredients (Eucommia ulmoides, gooseberry, and black garlic) have a preclinical capacity to restore microbial balance, attenuate insulin resistance, and exert neuroprotection. This review integrates these strands into a unified mechanistic and translational framework, positioning gut microbiota modulation through culturally grounded dietary strategies as a tractable approach to reducing the converging burdens of T2DM and AD in Asians.
SN - 2287-1098
SN - 2287-8602
ER -